Edwards Lifesciences Corporation Share-based Payment Arrangement, Expense, Tax Benefit
Edwards Lifesciences Corporation (EW) reported Share-based Payment Arrangement, Expense, Tax Benefit of $7.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense · last filed 2026-08-04
- Edwards Lifesciences Corporation share-based payment arrangement, expense, tax benefit for the quarter ending 2026-06-30 was $7.00M, a 14.75% increase year-over-year.
- Edwards Lifesciences Corporation share-based payment arrangement, expense, tax benefit for the quarter ending 2026-03-31 was $7.50M, a 15.38% increase year-over-year.
- Edwards Lifesciences Corporation share-based payment arrangement, expense, tax benefit for the quarter ending 2025-12-31 was $7.60M, a 4.11% increase year-over-year.
- Edwards Lifesciences Corporation share-based payment arrangement, expense, tax benefit for the quarter ending 2025-09-30 was $7.80M, a 30.00% increase year-over-year.
- Edwards Lifesciences Corporation share-based payment arrangement, expense, tax benefit for fiscal 2025 was $28.00M, a 12.90% increase from fiscal 2024.
- Edwards Lifesciences Corporation share-based payment arrangement, expense, tax benefit for fiscal 2024 was $24.80M, a 13.76% increase from fiscal 2023.
- Edwards Lifesciences Corporation share-based payment arrangement, expense, tax benefit for fiscal 2023 was $21.80M, a 11.22% increase from fiscal 2022.
- Edwards Lifesciences Corporation share-based payment arrangement, expense, tax benefit for fiscal 2022 was $19.60M, a 3.70% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense, Tax Benefit 3 month | Share-based Payment Arrangement, Expense, Tax Benefit 3 month as first filed | Share-based Payment Arrangement, Expense, Tax Benefit 6 month | Share-based Payment Arrangement, Expense, Tax Benefit 6 month as first filed | Share-based Payment Arrangement, Expense, Tax Benefit 9 month | Share-based Payment Arrangement, Expense, Tax Benefit 9 month as first filed | Share-based Payment Arrangement, Expense, Tax Benefit 12 month | Share-based Payment Arrangement, Expense, Tax Benefit 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $7.00M 10-Q · filed 2026-08-04 | $14.50M 10-Q · filed 2026-08-04 | $22.10M derived: sum of 3 quarters · filed 2026-08-04 | $29.90M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $7.50M 10-Q · filed 2026-05-06 | $15.10M derived: sum of 2 quarters · filed 2026-05-06 | $22.90M derived: sum of 3 quarters · filed 2026-05-06 | $29.00M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $7.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $15.40M derived: sum of 2 quarters · filed 2026-02-25 | $21.50M derived: sum of 3 quarters · filed 2026-08-04 | $28.00M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $7.80M 10-Q · filed 2025-11-05 | $13.90M derived: sum of 2 quarters · filed 2026-08-04 | $20.40M 10-Q · filed 2025-11-05 | $27.70M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $6.10M 10-Q · filed 2026-08-04 | $12.60M 10-Q · filed 2026-08-04 | $19.90M derived: sum of 3 quarters · filed 2026-08-04 | $25.90M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-31 | $6.50M 10-Q · filed 2026-05-06 | $13.80M derived: sum of 2 quarters · filed 2026-05-06 | $19.80M derived: sum of 3 quarters · filed 2026-05-06 | $25.80M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $7.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $13.30M derived: sum of 2 quarters · filed 2026-02-25 | $19.30M derived: sum of 3 quarters · filed 2026-02-25 | $24.80M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $6.00M 10-Q · filed 2025-11-05 | $12.00M derived: sum of 2 quarters · filed 2025-11-05 | $17.50M 10-Q · filed 2025-11-05 | $24.80M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $6.00M 10-Q · filed 2025-08-06 | $11.50M 10-Q · filed 2025-08-06 | $18.80M derived: sum of 3 quarters · filed 2026-02-25 | $23.50M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $5.50M 10-Q · filed 2025-05-06 | $6.20M 10-Q · filed 2024-04-29 | $12.80M derived: sum of 2 quarters · filed 2026-02-25 | $17.50M derived: sum of 3 quarters · filed 2026-02-25 | $23.00M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | $7.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $12.00M derived: sum of 2 quarters · filed 2026-02-25 | $17.50M derived: sum of 3 quarters · filed 2026-02-25 | $21.80M 10-K · filed 2026-02-25 | $24.10M 10-K · filed 2024-02-12 | |||
| 2023-09-30 | $4.70M 10-Q · filed 2024-11-06 | $5.80M 10-Q · filed 2023-10-27 | $10.20M derived: sum of 2 quarters · filed 2024-11-06 | $14.50M 10-Q · filed 2024-11-06 | $17.30M 10-Q · filed 2023-10-27 | $19.30M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-06-30 | $5.50M 10-Q · filed 2024-07-31 | $6.80M 10-Q · filed 2023-07-28 | $9.80M 10-Q · filed 2024-07-31 | $11.50M 10-Q · filed 2023-07-28 | $14.60M derived: sum of 3 quarters · filed 2025-02-28 | $19.50M derived: sum of 4 quarters · filed 2025-02-28 | ||
| 2023-03-31 | $4.70M 10-Q · filed 2024-04-29 | $9.10M derived: sum of 2 quarters · filed 2025-02-28 | $14.00M derived: sum of 3 quarters · filed 2025-02-28 | $19.90M derived: sum of 4 quarters · filed 2025-02-28 | ||||
| 2022-12-31 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $9.30M derived: sum of 2 quarters · filed 2025-02-28 | $15.20M derived: sum of 3 quarters · filed 2025-02-28 | $19.60M 10-K · filed 2025-02-28 | $21.60M 10-K · filed 2023-02-13 | |||
| 2022-09-30 | $4.90M 10-Q · filed 2023-10-27 | $10.80M derived: sum of 2 quarters · filed 2023-10-27 | $15.20M 10-Q · filed 2023-10-27 | $20.60M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-06-30 | $5.90M 10-Q · filed 2023-07-28 | $10.30M 10-Q · filed 2023-07-28 | $15.70M derived: sum of 3 quarters · filed 2024-02-12 | $20.40M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-03-31 | $4.40M 10-Q · filed 2023-04-28 | $9.80M derived: sum of 2 quarters · filed 2024-02-12 | $14.50M derived: sum of 3 quarters · filed 2024-02-12 | $19.40M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2021-12-31 | $5.40M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-12 | $10.10M derived: sum of 2 quarters · filed 2024-02-12 | $15.00M derived: sum of 3 quarters · filed 2024-02-12 | $18.90M 10-K · filed 2024-02-12 | ||||
| 2021-09-30 | $4.70M 10-Q · filed 2022-10-28 | $9.60M derived: sum of 2 quarters · filed 2022-10-28 | $13.50M 10-Q · filed 2022-10-28 | $17.40M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-06-30 | $4.90M 10-Q · filed 2022-07-29 | $8.80M 10-Q · filed 2022-07-29 | $12.70M derived: sum of 3 quarters · filed 2023-02-13 | $16.60M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2021-03-31 | $3.90M 10-Q · filed 2022-04-28 | $7.80M derived: sum of 2 quarters · filed 2023-02-13 | $11.70M derived: sum of 3 quarters · filed 2023-02-13 | $15.80M derived: sum of 4 quarters · filed 2023-02-13 | ||||
| 2020-12-31 | $3.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-13 | $7.80M derived: sum of 2 quarters · filed 2023-02-13 | $11.90M derived: sum of 3 quarters · filed 2023-02-13 | $15.40M 10-K · filed 2023-02-13 | ||||
| 2020-09-30 | $3.90M 10-Q · filed 2021-10-29 | $8.00M derived: sum of 2 quarters · filed 2021-10-29 | $11.50M 10-Q · filed 2021-10-29 | |||||
| 2020-06-30 | $4.10M 10-Q · filed 2021-07-30 | $7.60M 10-Q · filed 2021-07-30 | ||||||
| 2020-03-31 | $3.50M 10-Q · filed 2021-04-28 | |||||||
| 2019-12-31 | $14.80M 10-K · filed 2022-02-14 | |||||||
| 2018-12-31 | $13.40M 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |